Here are a few key events I will be watching closely for in the months ahead on stocks I think are buys at current levels.
A roundup of biotech names with actions pending at the FDA in coming weeks.
I've added to my positions in these names on yesterday's intraday silliness.
Sector M&A activity is likely to pick up next year benefiting the space.
We are coming my favorite part of earnings season -- when these small-caps report.
©1996-2018 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.